Why has my weight loss stopped on Mounjaro — and what should you do next?

Why your body slows down even when Mounjaro is still working

The most reassuring thing to know first: a plateau does not mean tirzepatide has stopped doing its job. It means your body has caught up with the new conditions you have created. As body weight falls, your basal metabolic rate drops too, a smaller body simply burns fewer calories at rest. This metabolic adaptation is well-documented and happens with every form of weight loss, not just medication-assisted approaches. The medicine is still reducing your appetite and slowing gastric emptying; the maths of your energy balance has just shifted.

There is also a hormonal piece. As fat stores shrink, the body increases production of appetite-stimulating hormones and decreases satiety signals, mechanisms that evolved to protect against famine. Tirzepatide counteracts some of this by activating both GIP and GLP-1 receptors, which is why it tends to produce greater average weight reduction than earlier single-pathway medicines in head-to-head trials. But it does not override adaptation completely. The clinical profile of tirzepatide shows the largest losses in the first six to twelve months, with a natural flattening curve as the body stabilises, this is expected, not alarming.

A plateau of one or two weeks is almost never meaningful. If you have stopped losing weight on Mounjaro and the standstill has lasted four to six weeks at a dose you have been on for some time, that is worth noting. The NHS's patient information on tirzepatide notes that your prescriber will review progress and decide whether continuing at the current dose, increasing it, or making lifestyle adjustments is appropriate, a prescriber who knows your history is the right person to make that call, not a quick fix from a forum.

The dose question: when titration is part of the answer

Mounjaro is licensed in the UK at six strengths (2.5, 5, 7.5, 10, 12.5, and 15 mg) and is typically increased in four-week steps as your prescriber sees fit. The starting dose exists primarily to let your system adjust; the therapeutic work builds as the dose rises. Many people experience a clear renewed response after each increase, which is one reason a plateau at, say, 5 or 7.5 mg does not mean you have reached your ceiling.

That said, a dose increase is not automatic or guaranteed. Tolerability matters. Your prescriber will weigh your side-effect profile, the pace of your current loss, and your overall clinical picture before recommending a change. Asking to go straight to the highest dose because progress has slowed is not how it works, and for good reason, a rushed titration often means worse nausea and a higher chance of stopping the medicine altogether.

If you are already at or near the maximum dose and weight has stalled, this is where the lifestyle factors in the next section carry most of their weight. You can read more about the broader clinical picture on our Mounjaro treatment overview page. For people wondering whether cost is influencing their decision to stay at a lower dose longer than necessary, the Mounjaro cost guide gives honest context about what private treatment involves, cutting corners on clinical review to save money is rarely a good trade when you are managing a course of treatment this closely tied to dose.

What you can actually change day to day

Tirzepatide reduces appetite, but it does not choose what you eat or whether you move. Once the initial appetite suppression becomes your new normal, old eating patterns can quietly creep back in, especially if meals have drifted smaller but also lower in protein and fibre. Protein is particularly important during weight loss because it preserves lean muscle mass; when the body loses fat and muscle together, the metabolic slowdown is more pronounced and the plateau harder to break.

Practical things worth reviewing if weight loss has stopped on Mounjaro: are you eating enough protein at each meal (roughly 25–35g is a useful benchmark, though personal targets depend on your weight and activity)? Are you sleeping enough? Poor sleep raises ghrelin (the appetite hormone) and can blunt the satiety effects of the medicine. Is your activity including any resistance training, even light bodyweight exercises? Muscle tissue is metabolically active in a way that steady-state cardio does not fully replicate.

The NHS patient information for tirzepatide recommends using the medicine alongside a reduced-calorie diet and increased physical activity, not because the medicine is insufficient, but because these inputs work together rather than separately. If you would find it useful to talk through your current routine, our aftercare team is available seven days a week.

When to involve your prescriber, and what that looks like at nume

A genuine stall (four or more weeks with no movement) at a stable dose is the clearest signal to book a clinical review. Your prescriber can assess whether the plateau is expected at this stage, whether a dose change is clinically appropriate, and whether anything in your health picture has shifted. They may also want to check that the medicine is being stored and used correctly, and our guide on how to dilute Mounjaro is one example of the practical handling information available if you have any questions about preparation.

At nume, clinical review is built into the process rather than bolted on. Every repeat order is reviewed by a GPhC-registered prescriber (a named clinician reads your case, not an automated system) and our aftercare team is on hand between orders too. If your pen arrived in the plain DPD box and you have been getting on with treatment, but something feels like it has stopped, that is exactly the kind of conversation our prescribers are here for. You can reach us through the FAQs or directly via the contact page.

If you are considering whether to continue, switch, or start treatment for the first time, check your eligibility through a free consultation and speak to one of our prescribers about where you are in the process.